Related Experiment Videos
Karyotypic evolution associated with loss of tumorigenicity
Journal of the National Cancer Institute
|March 1, 1979
Summary
Tumorigenicity loss in mouse plasmacytoma cell lines correlated with karyotypic changes. A defect in chromosome 15 persisted despite evolving oncogenicity, suggesting complex genetic alterations in cancer progression.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Mouse plasmacytoma is a B-cell malignancy.
- Specific chromosomal abnormalities, particularly in chromosome 15, are characteristic of mouse myelomas.
- Cell culture lines provide models for studying cancer progression.
Purpose of the Study:
- To investigate the relationship between karyotypic changes and loss of tumorigenicity in mouse plasmacytoma cell lines.
- To track chromosomal evolution during the loss of oncogenicity.
- To determine if the characteristic chromosome 15 defect is altered during this process.
Main Methods:
- Establishment of cell culture lines (SLU-5, DMS-402) from mouse plasmacytoma MOPC-21.
- Karyotypic analysis of the cell lines.
- Assessment of tumorigenicity in vivo (implied).
Main Results:
- A reproducible association was found between loss of tumorigenicity and specific karyotypic changes.
- The defect in chromosome 15, common in mouse myelomas, was not corrected or eliminated.
- Karyotypic evolution occurred progressively alongside the gradual loss of oncogenicity.
Conclusions:
- Karyotypic evolution, including a persistent chromosome 15 defect, accompanies the loss of tumorigenicity in these mouse plasmacytoma models.
- The findings suggest complex genetic alterations underlying changes in cancer cell behavior.